Please assess the completion status of the following clinical trial:

Trial Title: Evaluation of Alpha-Lipoic Acid in Diabetic Cardiomyopathy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Male or female adult age ≥ 18 years~* patient with diagnosed type 2 diabetes (history of pathological hyperglycemia according to WHO and HbA1c standards \>7% or ongoing treatment with oral antidiabetic agents).~* Patients with stable cardiomyopathy (no hospitalization in cardiology in the month before inclusion) with a left ventricular ejection fraction (LVEF) \<50%.~* patient who has signed an informed consent form~* For women of childbearing age: effective contraception followed for at least 3 months before the start of the study and agreeing to keep it for the duration of the study.~* affiliation to a social security scheme.~Exclusion Criteria:~subjects:~* With a coronary event in the year before inclusion.~* With symptoms of cardiac ischemia at inclusion.~* Pregnant or breastfeeding woman~* Severe renal insufficiency~* Using antioxidant molecules in the 6 months prior to inclusion.~* Using drugs that can activate PPARs (Fibrates, Telmisartan, Enalaprilat).~* Using anti-inflammatory drugs.~* Suffering from acute infectious diseases and inflammatory diseases.~* Hypersensitivity or a history of hypersensitivity reaction to gadoteric acid, meglumine or any drug containing gadolinium.~Non-inclusion criteria related to MRI:~* with an implanted vascular stent less than 6 weeks before the examination;~* carrier of an implanted biomedical device deemed not safe or unsafe in the list: http://www.mrisafety.com/TheList_search.asp;~* Beneficiary of an acquisition procedure that does not respect the conditions required by conditional use in a subject carrying an implanted biomedical material considered conditional in the list: http://www.mrisafety.com/TheList_search.asp;~* carrier of a ferromagnetic intraocular or intracranial foreign body close to the nerve structures;~* carrying biomedical equipment such as a cardiac, neural or sensory pacemaker (cochlear implant) or a ventricular bypass valve without medical and paramedical supervision trained to perform MRI in these subjects;

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Alpha-Lipoic Acid group (Type: ACTIVE_COMPARATOR): None
- placebo group (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).